« Back
Home /
DCC-2036

DCC-2036

Item no.	MOLN-M10095-500mg
Manufacturer	Molnova
CASRN	1020172-07-9
Amount	500 mg
Category	Reagents & Chemicals Other Chemicals
Type	Chemicals
Specific against	other
Purity	>98% (HPLC)
ECLASS 10.1	32160000
ECLASS 11.0	32160000
UNSPSC	12000000
Available
Brief description	DCC-2036 (Rebastinib) is a highly potent, non-ATP-competitive BCR-ABL1 inhibitor with IC50 of 0.8 and 4 nM for native ABL1 and gatekeeper mutant ABL1 T315I, respectively.
Molecular Weight	553, 5869
Note	Research use only, not for human use.
Stability	≥ 2 years
Storage	(-20℃)
Receptor	Bcr-Abl

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

Request product datasheet

Request safety datasheet

Simple Order Order Subscription

Amount: 500 mg

available

Delivery expected until 8/30/2024

Express Delivery: Save 4 days

Compare

Add to wishlist

Recommend by mail